Correlation Engine 2.0
Clear Search sequence regions


filter terms:
  • humans (1)
  • therapies (1)
  • Sizes of these terms reflect their relevance to your search.

    Systemic immune activation is increased in HIV-infected individuals, even in the setting of virus suppression with antiretroviral therapy. Although numerous factors may contribute, microbial products have recently emerged as potential drivers of this immune activation. In this Review, we describe the intestinal damage that occurs in HIV infection, the evidence for translocation of microbial products into the systemic circulation and the pathways by which these products activate the immune system. We also discuss novel therapies that disrupt the translocation of microbial products and the downstream effects of microbial translocation.

    Citation

    Netanya G Sandler, Daniel C Douek. Microbial translocation in HIV infection: causes, consequences and treatment opportunities. Nature reviews. Microbiology. 2012 Sep;10(9):655-66

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 22886237

    View Full Text